Please wait

EXHIBIT 107

Calculation of Filing Fee Table

Form S-3

(Form Type)

Assembly Biosciences, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

                         
     Security
Type		  

Security

Class

Title

   Fee
Calculation		   Amount
Registered(1)		  

Proposed
Maximum
Offering
Price Per

Share(2)

  

Maximum

Aggregate

Offering
Price

  

Fee

Rate

   Amount of
Registration
Fee		   Carry 
Forward 
Form 
Type 		   Carry 
Forward 
File 
Number 		   Carry 
Forward 
Initial
Effective 
Date 		  

Filing Fee
Previously

Paid in
Connection

with Unsold
Securities

to be

Carried
Forward

 
Newly Registered Securities
                         

Fees to Be

Paid

   Equity   Common Stock, par value $0.001 per share   457(o)   (1)(2)    (3)                 
                         

Fees to Be

Paid

   Equity   Preferred Stock, par value $0.001 per share   457(o)   (1)(2)    (3)                 
                         

Fees to Be

Paid

   Debt   Debt Securities   457(o)   (1)(2)    (3)                 
                         

Fees to Be

Paid

   Other   Warrants   457(o)   (1)(2)    (3)                 
                         

Fees to Be

Paid

   Other   Subscription Rights   457(o)   (1)(2)    (3)                 
                         

Fees to Be

Paid

   Other   Units(4)   457(o)   (1)(2)    (3)                 
                         

Fees to be

Paid

   Unallocated (Universal Shelf)   —   457(o)   (1)(2)    (3)    $250,000,000   0.00015310   $38,275          
                   
    Total Offering Amounts     $250,000,000   0.00015310   $38,275          
                   
    Total Fees Previously Paid         —          
                   
    Total Fee Offsets         $30,505.04          
                         
Net Fees Due                               $7,769.96                

 

(1)

Assembly Biosciences, Inc. (the “Company”) is hereby registering an indeterminate amount and number of each applicable identified class of the identified securities up to a proposed maximum aggregate offering price of $250,000,000, which may be offered from time to time at indeterminate prices, including securities that may be purchased by underwriters. The Company has estimated the proposed maximum aggregate offering price solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”). Securities registered hereunder may be sold separately, together or as units with other securities registered hereunder.

(2)

Pursuant to Rule 416 under the Securities, this registration statement shall also cover any additional shares of the registrant’s securities that become issuable by reason of any share splits, share dividends or similar transactions.

(3)

Estimated solely for the purpose of calculating the registration fee. No separate consideration will be received for shares of common stock that are issued upon conversion of debt securities or preferred stock or upon exercise of common stock warrants registered hereunder. The aggregate maximum offering price of all securities issued pursuant to this registration statement will not exceed $250,000,000.

(4)

Any securities registered under the registration statement may be sold separately or as units with other securities registered under the registration statement.

Table 2: Fee Offset Claims and Sources

 

                       
     Registrant
or Filer
Name		   Form
or
Filing
Type		   File
Number		   Initial
Filing
Date		   Filing
Date		   Fee
Offset
Claimed		   Security
Type
Associated
with Fee
Offset
Claimed		   Security
Title
Associated
with Fee
Offset
Claimed		   Unsold
Securities
Associated
with Fee
Offset
Claimed		   Unsold
Aggregate
Offering
Amount
Associated
with Fee
Offset
Claimed		  

Fee Paid with

Fee Offset
Source

 
Rule 457(p)
                       

Fee Offset

Claims

   Assembly Biosciences,  Inc.   S-3   333-248469    8/28/2020      $30,505.04(5)    Unallocated  (Universal)  Shelf   Unallocated  (Universal)  Shelf   Unallocated  (Universal)  Shelf   $235,015,702.17     
                       

Fee Offset

Sources

   Assembly Biosciences,  Inc.   S-3   333-248469        8/28/2020                        $30,505.04(5)

 

(5) 

Pursuant to Rule 457(p) under the Securities Act, a registration fee of $38,940 was paid with respect to securities available for issuance under a Registration Statement on Form S-3 (File No. 333-248469) filed by the registrant on August 28, 2020 and declared effective on September 4, 2020 (the Prior Registration Statement). The Registrant hereby offsets the total registration fee of $38,275 due under this registration statement by $30,505.04 (calculated at the fee rate in effect at the date of the Prior Registration Statement of $129.80 per million dollars), which represents the portion of the registration fee previously paid with respect to $235,015,702.17 of unsold securities previously registered under the Prior Registration Statement. The offering of the unsold securities registered under the Prior Registration Statement has been terminated.